Arix Bioscience plc
Director/PDMR Shareholdings
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
a)
|
Name
|
Robert Lyne |
|||
2
|
Reason for the notification
|
||||
a)
|
Position/status
|
CEO and General Counsel |
|||
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
a)
|
Name
|
Arix Bioscience plc |
|||
b)
|
LEI
|
213800OVT3AHQCXNIX43
|
|||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
a)
|
Description of the financial instrument, type of instrument |
Arix Bioscience plc Ordinary shares of 0.001 pence each |
|||
|
|
||||
Identification code |
GB00BD045071 |
||||
b)
|
Nature of the transaction
|
Share purchase |
|||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
1 20.00p |
41,666.00 |
|
|
d)
|
Aggregated information |
|
|||
|
|
||||
- Aggregated volume |
N/A single transaction |
||||
|
|
||||
- Price |
£49,999.20 |
||||
|
|
||||
e)
|
Date of the transaction
|
16 December 2021 |
|||
f)
|
Place of the transaction
|
London Stock Exchange |
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
a)
|
Name
|
Peregrine Moncreiffe |
|||
2
|
Reason for the notification
|
||||
a)
|
Position/status
|
Non-Executive Director and Chair of the Board |
|||
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
a)
|
Name
|
Arix Bioscience plc |
|||
b)
|
LEI
|
213800OVT3AHQCXNIX43
|
|||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
a)
|
Description of the financial instrument, type of instrument |
Arix Bioscience plc Ordinary shares of 0.001 pence each |
|||
|
|
||||
Identification code |
GB00BD045071 |
||||
b)
|
Nature of the transaction
|
Share purchase |
|||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
1 19.00p |
84,000.00 |
|
|
d)
|
Aggregated information |
|
|||
|
|
||||
- Aggregated volume |
N/A single transaction |
||||
|
|
||||
- Price |
£99,959.98 |
||||
|
|
||||
e)
|
Date of the transaction
|
16 December 2021 |
|||
f)
|
Place of the transaction
|
London Stock Exchange |
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
||||
a)
|
Name
|
Sir Michael Bunbury |
|||
2
|
Reason for the notification
|
||||
a)
|
Position/status
|
Non-Executive Director and Senior Independent Director (SID) |
|||
b)
|
Initial notification /Amendment
|
Initial Notification |
|||
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
a)
|
Name
|
Arix Bioscience plc |
|||
b)
|
LEI
|
213800OVT3AHQCXNIX43
|
|||
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
a)
|
Description of the financial instrument, type of instrument |
Arix Bioscience plc Ordinary shares of 0.001 pence each |
|||
|
|
||||
Identification code |
GB00BD045071 |
||||
b)
|
Nature of the transaction
|
Share purchase |
|||
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
|
|
|
1 19.00p |
40,000.00 |
|
|
d)
|
Aggregated information |
|
|||
|
|
||||
- Aggregated volume |
N/A single transaction |
||||
|
|
||||
- Price |
£47,600.00 |
||||
|
|
||||
e)
|
Date of the transaction
|
16 December 2021 |
|||
f)
|
Place of the transaction
|
London Stock Exchange |
For further information please contact:
Derringtons Limited, Company Secretary
+44 20 8819 6486
Ends.